See more : Sichuan Shengda Forestry Industry Co., Ltd (002259.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Blue Water Vaccines, Inc. (BWV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Blue Water Vaccines, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Alembic Pharmaceuticals Limited (APLLTD.NS) Income Statement Analysis – Financial Results
- HIKARI FOOD SERVICE CO. LTD. (138A.T) Income Statement Analysis – Financial Results
- Mulsanne Group Holding Limited (1817.HK) Income Statement Analysis – Financial Results
- WisdomTree U.S. Corporate Bond Fund (QIG) Income Statement Analysis – Financial Results
- SK Discovery Co., Ltd. (006120.KS) Income Statement Analysis – Financial Results
Blue Water Vaccines, Inc. (BWV)
About Blue Water Vaccines, Inc.
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 4.13M | 1.33M | 524.91K | 60.17K |
| General & Administrative | 9.35M | 2.09M | 1.10M | 820.06K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.35M | 2.09M | 1.10M | 820.06K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 13.48M | 3.42M | 1.62M | 880.23K |
| Cost & Expenses | 13.48M | 3.42M | 1.62M | 880.23K |
| Interest Income | 0.00 | 0.00 | 22.60K | 58.32K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -61.41K | 4.89K | 3.06K | 573.00 |
| EBITDA | -13.48M | -3.41M | -1.62M | -879.66K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -13.48M | -3.42M | -1.62M | -880.23K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 61.41K | 0.00 | 22.60K | 58.32K |
| Income Before Tax | -13.42M | -3.42M | -1.60M | -821.92K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -129.57K | 0.00 | -22.60K | -58.32K |
| Net Income | -13.29M | -3.42M | -1.58M | -763.60K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -1.08 | -0.31 | -0.14 | -0.07 |
| EPS Diluted | -1.08 | -0.31 | -0.14 | -0.07 |
| Weighted Avg Shares Out | 12.27M | 10.91M | 11.05M | 11.05M |
| Weighted Avg Shares Out (Dil) | 12.27M | 10.91M | 11.05M | 11.05M |
Why Is Blue Water Vaccines (BWV) Stock Up Today?
Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022
U.S. IPO Weekly Recap: The IPO Market's Micro-Cap Run Continues With 2 Small Healthcare Deals
Source: https://incomestatements.info
Category: Stock Reports